Morgan Stanley Tekla Life Sciences Investors Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Morgan Stanley holds 489,687 shares of HQL stock, worth $7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

489,687

Previous 490,140 0.09%

Holding current value

$7 Million

Previous $6.95 Million 6.32%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$14.26 - $15.78 $6,459 - $7,148	-453 Reduced 0.09%	489,687 $7.38 Million
Q2 2024 Oct 17, 2024	BUY	$12.79 - $14.27 $76,253 - $85,077	5,962 Added 1.23%	490,140 $6.95 Million
Q2 2024 Aug 14, 2024	BUY	$12.79 - $14.27 $76,253 - $85,077	5,962 Added 1.23%	490,140 $6.95 Million
Q1 2024 Oct 17, 2024	SELL	$13.38 - $14.33 $79,771 - $85,435	-5,962 Reduced 1.22%	484,178 $6.6 Million
Q1 2024 Aug 16, 2024	BUY	$13.38 - $14.33 $721,342 - $772,558	53,912 Added 12.53%	484,178 $6.6 Million
Q1 2024 May 15, 2024	BUY	$13.38 - $14.33 $721,342 - $772,558	53,912 Added 12.53%	484,178 $6.6 Million
Q4 2023 Aug 16, 2024	SELL	$11.35 - $13.6 $679,569 - $814,286	-59,874 Reduced 12.22%	430,266 $5.79 Million
Q4 2023 Feb 13, 2024	SELL	$11.35 - $13.6 $2.63 Million - $3.15 Million	-231,372 Reduced 34.97%	430,266 $5.79 Million
Q3 2023 Nov 15, 2023	BUY	$12.38 - $13.69 $1.02 Million - $1.13 Million	82,703 Added 14.29%	661,638 $8.25 Million
Q2 2023 Aug 14, 2023	BUY	$13.13 - $14.17 $635,492 - $685,828	48,400 Added 9.12%	578,935 $7.84 Million
Q1 2023 May 15, 2023	BUY	$13.37 - $14.94 $1.16 Million - $1.29 Million	86,482 Added 19.48%	530,535 $7.39 Million
Q4 2022 Feb 14, 2023	BUY	$13.55 - $15.23 $497,366 - $559,032	36,706 Added 9.01%	444,053 $6.31 Million
Q3 2022 Nov 14, 2022	BUY	$13.39 - $16.31 $119,358 - $145,387	8,914 Added 2.24%	407,347 $5.56 Million
Q2 2022 Oct 27, 2022	SELL	$13.11 - $17.02 $452,504 - $587,462	-34,516 Reduced 7.97%	398,433 $5.67 Million
Q2 2022 Aug 15, 2022	SELL	$13.11 - $17.02 $452,504 - $587,462	-34,516 Reduced 7.97%	398,433 $5.67 Million
Q1 2022 Oct 27, 2022	BUY	$15.35 - $19.29 $529,820 - $665,813	34,516 Added 8.66%	432,949 $7.16 Million
Q1 2022 May 13, 2022	BUY	$15.35 - $19.29 $819,858 - $1.03 Million	53,411 Added 14.07%	432,949 $7.16 Million
Q4 2021 Feb 14, 2022	SELL	$18.5 - $21.59 $691,955 - $807,530	-37,403 Reduced 8.97%	379,538 $7.3 Million
Q3 2021 Nov 15, 2021	BUY	$20.27 - $22.67 $8.45 Million - $9.45 Million	416,941 New	416,941 $8.67 Million

Others Institutions Holding HQL

# of Institutions

Shares Held

9.29M

Call Options Held

Put Options Held

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account